Milestone Scientific receives non-compliance notification from NYSE American

Milestone Scientific (MLSS) received a letter from NYSE American dated October 8, stating that the Company is not in compliance with the continued listing standards set forth in Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide. Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4M or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years, and Section 1003(a)(iii) requires stockholders’ equity of $6M or more if it has reported losses from continuing operations and/or net losses in its five most recent fiscal years. Based on the Company’s Form 10-Q for the period ended June 30, 2025, Milestone Scientific reported stockholders’ equity of approximately $3.3M and has experienced losses in each of its five most recent fiscal years ended December 31, 2024. As a result, the Company is not currently in compliance with Sections 1003(a)(ii) and and is not eligible for any exemption under Section 1003(a) of the Company Guide. Pursuant to Section 1009 of the Company Guide, the Letter requires the Company to submit a plan of compliance by November 7, 2025, detailing actions it has taken or will take to regain compliance with the continued listing standards by April 8, 2027. The Company intends to fully cooperate with the NYSE American and submit its Plan within the prescribed timeframe.